These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3422071)

  • 1. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
    Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases.
    Gresser I; Maury C; Belardelli F
    Int J Cancer; 1987 Jun; 39(6):789-92. PubMed ID: 2438237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
    Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
    Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
    Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
    J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
    Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
    Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
    Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
    Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
    Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
    J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
    Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
    Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Belardelli F; Maunoury MT; Machover D
    J Natl Cancer Inst; 1988 Mar; 80(2):126-31. PubMed ID: 3422696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
    Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
    Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
    Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
    J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
    Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
    Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize.
    Belardelli F; Ferrantini M; Maury C; Santurbano L; Gresser I
    Int J Cancer; 1984 Sep; 34(3):389-95. PubMed ID: 6207117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of IFN-alpha/beta inhibits the development of visceral tumor metastases.
    Kaido TJ
    J Interferon Cytokine Res; 1997 Jan; 17(1):31-6. PubMed ID: 9041469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver.
    Gresser I; Maury C; Bandu MT; Belardelli F
    Int J Cancer; 1990 Feb; 45(2):364-71. PubMed ID: 2406205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.
    Ferrantini M; Pulciani S; Proietti E; Lespinats G; Anastasi A; Ciolli V; Rizza P; Belardelli F
    Clin Exp Metastasis; 1989; 7(6):609-25. PubMed ID: 2476272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
    Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
    Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
    Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.
    Belardelli F; Gresser I; Maury C; Maunoury MT
    Int J Cancer; 1982 Dec; 30(6):813-20. PubMed ID: 6186614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anti-tumor effects of combined IL-1/IFN-alpha/beta therapy in mice injected with metastatic Friend erythroleukemia cells.
    Belardelli F; Gabriele L; Proietti E; Sestili P; Peretti M; Rozera C; Gresser I
    Int J Cancer; 1991 Sep; 49(2):274-8. PubMed ID: 1879971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.